https://www.selleckchem.com/pr....oducts/tenalisib-rp6
Background Hepatic artery thrombosis (HAT) following liver transplantation is a serious complication that may lead to graft loss and ultimately death. Retransplantation and surgical recanalization for HAT have traditionally been the predominant methods of treatment. However, with the development of endovascular therapies, including percutaneous transluminal angioplasty, thrombolysis, and stent insertion, these methods are now mainly used because they allow prompt management. Methods From January 2005 to December 2018, 756 patie
Like
Comment
Share
